VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 456 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2014. The put-call ratio across all filers is 0.78 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $205,328,000 | -96.4% | 1,565 | -96.6% | 0.04% | -96.2% |
| Q2 2014 | $5,733,415,000 | -4.5% | 45,460 | -0.2% | 1.11% | -14.9% |
| Q1 2014 | $6,003,538,000 | -35.9% | 45,540 | -42.9% | 1.30% | -36.7% |
| Q4 2013 | $9,361,006,000 | +6.7% | 79,736 | -5.2% | 2.06% | -2.0% |
| Q3 2013 | $8,773,736,000 | +20.6% | 84,096 | -0.5% | 2.10% | +7.2% |
| Q2 2013 | $7,274,707,000 | – | 84,511 | – | 1.96% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,373,210 | $47,796,000 | 39.06% |
| Claren Road Asset Management, LLC | 77,527 | $1,561,000 | 18.46% |
| Okumus Fund Management Ltd. | 4,242,012 | $85,434,000 | 14.79% |
| Chou Associates Management | 1,446,843 | $29,139,000 | 11.12% |
| FARLEY CAPITAL L.P. | 307,458 | $6,192,000 | 9.65% |
| HAP Trading, LLC | 3,129,700 | $112,397,000 | 6.58% |
| Pershing Square Capital Management | 21,591,122 | $434,845,000 | 5.79% |
| NORTH TIDE CAPITAL, LLC | 2,500,000 | $50,350,000 | 5.61% |
| Convector Capital Management, LP | 192,000 | $3,867,000 | 5.34% |
| Nebula Capital Management, LP | 31,770 | $640,000 | 5.07% |